Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Depot Extension Study
NCT00558298Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Janssen Pharmaceutical. Started Feb 2000; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00558298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558298.